Metric Finance
LearnFAQ
LearnFAQ

Learn / EBS

NYSE: EBS

Emergent BioSolutions (EBS) stock, explained like you're 5

Emergent BioSolutions trades on the New York Stock Exchange under the ticker EBS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 362 million dollars.

Ticker
EBS
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 362 million dollars

Is Emergent BioSolutions a small, medium or large cap company?

No. Emergent BioSolutions is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 362 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Emergent BioSolutions makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves EBS stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Emergent BioSolutions Inc. (EBS) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • symbol__ Stock Quote Price and Forecast (CNN)
  • Emergent BioSolutions Inc. (EBS) stock price, news, quote and history (Yahoo Finance Singapore)
  • Why is Emergent Biosolutions stock sliding today? (Investing.com)
  • $EBS stock is down 13% today. Here's what we see in our data. (Quiver Quantitative)

Follow EBS in your daily brief

Each trading day at 5 PM ET we post what happened to Emergent BioSolutions and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow EBS

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Emergent BioSolutions stock

What does Emergent BioSolutions do?

Emergent BioSolutions trades on the New York Stock Exchange under the ticker EBS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 362 million dollars.

What is the ticker symbol for Emergent BioSolutions?

Emergent BioSolutions trades under the ticker EBS on the New York Stock Exchange.

What is Emergent BioSolutions's market cap?

Emergent BioSolutions is a small cap stock with a market cap of about 362 million dollars.

How does Emergent BioSolutions make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves EBS stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow EBS stock every day?

Add EBS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow EBS daily

A free brief on Emergent BioSolutions and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare EBS: EBS vs NVS, EBS vs AZN, EBS vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed